Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair"

Epilepsia. 2018 Apr;59(4):900-901. doi: 10.1111/epi.14062.

Eugen Trinka^{1

2

3}, José Francisco Rocha⁴, Patrício Soares-da-Silva^{4

5

6}

¹ Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Salzburg, Austria.
² Center for Cognitive Neuroscience, Salzburg, Austria.
³ Department of Public Health and Health Technology Assessment, University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
⁴ Department of Research and Development, BIAL-Portela & Cª, Coronado, Portugal.
⁵ Pharmacology and Therapeutics Unit, Department of Biomedicine, Faculty of Medicine, University Porto, Porto, Portugal.
⁶ MedInUP, Center for Drug Discovery and Innovative Medicines, University Porto, Porto, Portugal.

No abstract available

Publication types